Company Information
ISIN Code
HALEON-PK
Sector
PHARMACEUTICALS
Industry
PHARMACEUTICALS
CEO
Qawi Naseer
Website
Phone
9222210952630
Company Size
481 employees
Address
11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600
About the Company
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.
Employee History
| Year | Number of Employees |
|---|---|
| 2025 | 447 |
| 2024 | 447 |
| 2023 | 481 |
| 2022 | 478 |
| 2021 | 459 |
Recent Announcements (Last 6 Months)
| Date | Title | Attachments |
|---|---|---|
| 2026-06-10 | Prior Publication of Reminder for Conversion of Physical Shares to Book Entry Form & Unclaimed Dividend(s) / Share Certificates | Image PDF |
| 2026-06-11 | Reminder for Conversion of Physical Shares to Book Entry Form & Unclaimed Dividend(s) / Share Certificates | Image PDF |
| 2026-08-20 | Notice of Board of Directors Meeting - (Q2-2026) | Image PDF |
| 2026-08-27 | Financial Results for the Quarter Ended 30 June 2026 | Image PDF |
| 2026-08-27 | Change of Head of Internal Audit | Image PDF |
| 2026-08-28 | Annual Environment Excellence Award 2026 by the National Forum for Environment & Health (NFEH) | Image PDF |
| 2026-08-28 | Transmission of Quarterly Report for the Period Ended 30 June 2026 | Image PDF |
| 2026-08-31 | Prior Publication of Notice of Interim Cash Dividend and Share Book Closure | Image PDF |
| 2026-09-01 | Notice of Interim Cash Dividend and Share Book Closure | Image PDF |
| 2026-09-16 | Prior Publication of Notice of Credit of Interim Cash Dividend | Image PDF |
| 2026-10-30 | Disclosure of Material Information | Image PDF |
| 2026-09-17 | Credit of Interim Cash Dividend | Image PDF |
| 2026-10-21 | Notice of Board of Directors Meeting - (Q3-2026) | Image PDF |
| 2026-10-29 | Financial Results for the Quarter Ended 30 September 2026 | Image PDF |
| 2026-10-30 | Transmission of Quarterly Report for the Period Ended 30 September 2026 | Image PDF |
Insider Transactions
| Date | Name | Position | Action | Quantity | Rate (Rs.) | Attachment |
|---|---|---|---|---|---|---|
| 2025-06-02 | Qawi Naseer | Executive Director | Buy | 3 | 729.00 | View |
| 2025-06-02 | Farhan Muhammad Haroon | Non-Executive Director | Sell | 3 | 729.00 | View |
| 2025-03-21 | Farhan Muhammad Haroon | Executive Director | Buy | 1 | 808.00 | View |
| 2024-09-16 | Babar Sharif | Executive | Sell | 300 | 471.41 | View |
Price History (Last 30 Days)
| Date | Price (Rs.) | Volume | Market Cap |
|---|---|---|---|
| 2026-11-05 | 686.87 | 37.91K | 80.4B |
| 2026-11-04 | 669.26 | 106.99K | 78.34B |
| 2026-11-03 | 656.33 | 6.75K | 76.83B |
| 2026-11-02 | 650.73 | 17.49K | 76.17B |
| 2026-10-30 | 658.80 | 50.82K | 77.12B |
| 2026-10-29 | 661.25 | 58.07K | 77.4B |
| 2026-10-28 | 658.64 | 12.92K | 77.1B |
| 2026-10-27 | 661.68 | 13.18K | 77.45B |
| 2026-10-26 | 663.13 | 14.87K | 77.62B |
| 2026-10-23 | 673.68 | 16.59K | 78.86B |
| 2026-10-22 | 670.64 | 10.97K | 78.5B |
| 2026-10-21 | 677.73 | 20.39K | 79.33B |
| 2026-10-20 | 670.90 | 16.84K | 78.53B |
| 2026-10-19 | 677.36 | 9.55K | 79.29B |
| 2026-10-16 | 684.36 | 17.08K | 80.11B |
| 2026-10-15 | 678.42 | 21.03K | 79.41B |
| 2026-10-14 | 678.29 | 6.64K | 79.4B |
| 2026-10-13 | 676.00 | 18.06K | 79.13B |
| 2026-10-12 | 679.74 | 10.29K | 79.57B |
| 2026-10-09 | 685.40 | 70.94K | 80.23B |
| 2026-10-08 | 673.67 | 19.22K | 78.86B |
| 2026-10-07 | 682.30 | 7.87K | 79.87B |